New Drug Information Summaries

https://www.cancer.gov/about-cancer/treatment/drugs Afamitresgene autoleucel (Tecelra) is approved to treat synovial sarcoma that has spread to other parts of the body or cannot be removed by surgery. https://www.cancer.gov/about-cancer/treatment/drugs/afamitresgene-autoleucel Imetelstat sodium (Rytelo) is approved to treat certain types of myelodysplastic syndrome in adults with anemia who need blood transfusions and have not responded to other treatments. https://www.cancer.gov/about-cancer/treatment/drugs/imetelstat-sodium Tovorafenib (Ojemda) is approved to treat low-grade glioma in children aged 6 months and older. This approval is for slow-growing (low-grade) tumors that have an abnormal BRAF gene and have come back or did not get better with other treatment. https://www.cancer.gov/about-cancer/treatment/drugs/tovorafenib Vorasidenib citrate (Voranigo) is approved to treat astrocytoma or oligodendroglioma brain tumors in adults and children aged 12 years and older after surgery to partially or completely remove grade 2 tumors that have an abnormal IDH1 or IDH2 gene. https://www.cancer.gov/about-cancer/treatment/drugs/vorasidenib-citrate